Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis

International Journal of Experimental Pathology

Volumn 86, Issue 2, 2005, Pages 81-89

  Chen, Ke Min ^a   Lee, Hsiu Hsiung ^a   Chou, Hui Lin ^a   Liu, Jer Yuh ^a   Tsai, Bo Cyuan ^a   Lai, Shih Chan ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiostrongylus cantonensis; Meningitis; MMP 9; TIMP 1

Indexed keywords

COMPLEMENTARY DNA; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOSTRONGYLUS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; EOSINOPHIL MENINGITIS; EOSINOPHILIA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MENINGITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM HELMINTHIASIS; EOSINOPHILIA; MALE; MATRIX METALLOPROTEINASE 9; MENINGITIS; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRONGYLIDA INFECTIONS; SUBARACHNOID SPACE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 17144385127     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2005.00413.x     Document Type: Article

References (33)

1. Alicata J.E. & Jindrak K. (1970) Angiostrongylosis in the Pacific and Southeast Asia. Springfield, IL: Thomas.
2. Ash L.R. (1970) Diagnostic morphology of the third-stage larvae of Angiostrongylus cantonensis, Angiostrongylus vasorum, Aelurostrongylus abstrusus and Anafilaroides rostratus (Nematoda: Metastrongyloidea). J. Parasitol. 56, 249-253.
3. Betsuyaku T., Fukuda Y., Parks W.C., Shipley J.M., Senior R.M. (2000) Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157, 525-535.
4. Bottomley K.M., Johnson W.H., Walter D.S. (1998) Matrix metalloproteinase inhibitors in arthritis. J. Enzyme Inhib. 13, 79-101.
5. Damjanov L, McCue P.A., Chansky M. (1996) Nervous system. In: Histopathology a Color Atlas, and Textbook. (ed. J. Velker). New York, USA: Williams & Wilkins, pp. 459-489.
6. Davson H. & Segal M.B. (1995) The Proteins and other macromolecules of the CSF. In: Physiology of the CSF and of the Blood-Brain Barrier. (eds H. Davson, M.B. Segal). New York: CRC, pp. 573-606.
7. Goetzl E.J., Banda M.J., Leppert D. (1996) Matrix metalloproteinases in immunity. J. Immunol. 156, 1-4.
8. Gomez, D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122.
9. Herron G.S., Werb Z., Dwyer K., Banda M.J. (1986) Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261, 2810-2813.
10. Kaczmarek L., Lapinska-Dzwonek J., Szymczak S. (2002) Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? New EMBO member's review. EMBO J. 21, 6643-6648.
11. Kieseier B.C., Paul R., Koedel U. et al. (1999) Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122, 1579-1587.
12. Kolb S.A., Lahrtz F., Paul R., Leppert D., Nadal D., Pfister H.W. (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84, 143-150.
13. Leppert D., Ford J., Stabler G. et al. (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121, 2327-2334.
14. Lindo J.F., Waugh C., Hall J. et al. (2002) Enzootic Angiostrongylus cantonensis in rats and snails after an outbreak of human eosinophilic meningitis, Jamaica. Emerg. Infect. Dis. 8, 324-326.
15. Lukes A., Mun-Bryce S., Lukes M., Rosenberg G.A. (1999) Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol. Neurobiol. 19, 267-284.
16. Marchi N., Fazio V., Cucullo L. et al. (2003) Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J. Neurosci. 23, 1949-1955.
17. Matsuura E., Umehara F., Hashiguchi T., Fujimoto N., Okada Y., Osame M. (2000) Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J. Neurol. Sci. 173, 45-52.
18. Nagase H. (1997) Activation mechanism of matrix metalloproteinases. Biol. Chem. 378, 151-160.
19. Nagase H. & Woessner J.F. Jr. (1999) Matrix metalloproteinases: a mini review. J. Biol. Chem. 274, 21491-21494.
20. Nielsen B.S., Timshel S., Kjeldsen L. et al. (1996) 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer 65, 57-62.
21. Okada S., Kita H., George T.J., Gleich G.J., Leiferman K.M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17, 519-528.
22. Parsons J.C. & Grieve R.B. (1990) Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis. J. Parasitol. 76, 53-58.
23. Paul R., Lorenzl S., Koedel U. et al. (1998) Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44, 592-600.
24. Price N.M., Farrar J., Chau T.T.H., Mai N.T.H., Hien T.T., Friedland J.S. (2001) Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J. Immunol. 166, 4223-4230.
25. Risau W. & Wolburg H. (1990) Development of the blood-brain barrier. Trends Neurosci. 13, 174-178.
26. Sasaki O., Sugaya H., Ishida K., Yoshimura K. (1993) Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse. Parasite Immunol. 15, 349-354.
27. Sugaya H. & Yoshimura K. (1988) T-cell-dependent eosinophilia in the cerebrospinal fluid of the mouse infected with Angiostrongylus cantonensis. Parasite Immunol. 10, 127-138.
28. Vaillant B., Chiaramonte M.G., Cheever A.W., Soloway P.D., Wynn T.A. (2001) Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 167, 7017-7026.
29. Welgus H.G., Campbell E.J., Cury J.D., Eisen A.Z., Senior R.M., Wilhelm S.M. (1990) Neutral metalloproteinases produced by human mononuclear phagocytes. J. Clin. Invest. 86, 1496-1502.
30. Weller P.F. & Liu L.X. (1993) Eosinophilic meningitis. Semin. Neurol. 13, 161-168.
31. Yoshimura K., Sugaya H., Ishida K. (1994) The role of eosinophils in Angiostrongylus cantonensis infection. Parasitol. Today 10, 231-233.
32. Yoshimura K., Sugaya H., Kawamura K., Kumagai M. (1988) Ultrastructural and morphometric analyses of eosinophils from the cerebrospinal fluid of the mouse and guinea pig infected with Angiostrongylus cantonensis. Parasite Immunol. 10, 411-423.
33. Yurchenko P.D. & Schittney J.C. (1990) Molecular architecture of the basement membrane. FASEB J. 4, 1577-1590.